Casi Pharmaceuticals Inc (CASI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Casi Pharmaceuticals Inc-Aktie (CASI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2022-09-30	2022-06-30	2022-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
Revenues	19.13% 10.21	8.573	9.062
Cost Of Revenue	19.63% 4.247	3.55	3.758
Gross Profit	18.77% 5.966	5.023	5.304
Operating Expenses	3.52% 12.32	12.77	12.59
Benefits Costs and Expenses	5.17% 15.24	16.07	17.46
Costs And Expenses	3.52% 12.32	12.77	12.59
Provision For Loan, Lease, And Other Losses	-	-	-
Depreciation and Amortization	3,454% 0.462	0.013	0.092
Operating Income/Loss	17.97% -6.354	-7.746	-7.29
Net Interest Income/Expense	132.50% -0.013	0.04	0.074
Interest Income/Expense After Provision For Losses	132.50% -0.013	0.04	0.074
Income/Loss From Continuing Operations Before Tax	32.96% -5.023	-7.493	-8.40
Income/Loss From Continuing Operations After Tax	34.60% -5.023	-7.68	-8.596
Net Income/Loss	32.96% -5.023	-7.493	-8.40
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	0.178	-	-
Basic Average Shares	0.00% 13.61	13.61	137.96
Diluted Average Shares	0.00% 13.61	13.61	137.96
Basic Earnings Per Share	32.14% -0.38	-0.56	-0.06
Diluted Earnings Per Share	32.14% -0.38	-0.56	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%